Patents by Inventor Marco Kordova

Marco Kordova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing torsemide intermediate
    Patent number: 6670478
    Abstract: The present invention relates to new methods for the synthesis of torsemide and the torsemide synthetic intermediate, (3-sulfonylchloride-4-chloro)pyridine.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: December 30, 2003
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventor: Marco Kordova
  • PROCESS FOR PREPARING TORSEMIDE INTERMEDIATE
    Publication number: 20030212277
    Abstract: The present invention relates to new methods for the synthesis of torsemide and the torsemide synthetic intermediate, (3-sulfonylchloride-4-chloro)pyridine.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 13, 2003
    Inventor: Marco Kordova
  • Processes for preparing torsemide intermediate
    Patent number: 6635765
    Abstract: The present invention relates to new methods for the synthesis of torsemide and the torsemide synthetic intermediate, (3-sulfonylchloride-4-chloro)pyridine.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: October 21, 2003
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventor: Marco Kordova
  • Stable pharmaceutical formulation comprising torsemide modification II
    Publication number: 20030022921
    Abstract: Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.
    Type: Application
    Filed: February 8, 2002
    Publication date: January 30, 2003
    Inventors: Minutza Leibovici, Ruth Tenengauzer, Mira Kopel, Judith Aronhime, Marco Kordova
  • Stable pharmaceutical formulation comprising torsemide modification II
    Patent number: 6482417
    Abstract: Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: November 19, 2002
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Minutza Leibovici, Ruth Tenengauzer, Mira Kopel, Judith Aronhime, Marco Kordova
  • Micronized torsemide
    Publication number: 20020120147
    Abstract: The present invention relates to torsemide having relatively small particles, and corresponding relatively large surface area. In one embodiment, the invention relates to torsemide and formulations containing torsemide having a mean particle diameter of less than 200 micrometers.
    Type: Application
    Filed: August 14, 2001
    Publication date: August 29, 2002
    Inventors: Marco Kordova, Anchel Schwartz, Ben-Zion Dolitzky, Judith Aronhime, David Leonov, Shlomo Zavurov
  • Stable pharmaceutical formulation comprising torsemide modification II
    Publication number: 20020035135
    Abstract: Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.
    Type: Application
    Filed: February 21, 2001
    Publication date: March 21, 2002
    Inventors: Minutza Leibovici, Ruth Tenengauzer, Mira Kopel, Judith Aronhime, Marco Kordova
  • Novel processes for preparing torsemide intermediate
    Publication number: 20020019537
    Abstract: The present invention relates to new methods for the synthesis of torsemide and the torsemide synthetic intermediate, (3-sulfonylchloride-4-chloro)pyridine.
    Type: Application
    Filed: March 20, 2001
    Publication date: February 14, 2002
    Inventor: Marco Kordova